Antagonists of prostaglandin D2 receptors
US8071807B2 · kind B2 · utility
7Cited by
10References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2009 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Apr 21, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.